Shun Luo

Shanghai, China
Dr. Shun Luo is Founder and President of Jianshun Biosciences Co., Ltd. and Thousand Oaks Biopharmaceuticals Co., Ltd. Dr. Luo has more than 25 years of experience in biopharmaceutical and biotechnology industries. He started his industry career as Principal Investigator at Ares Serono Group. Later Dr. Luo worked for Beckman Coulter, JRH/SAFC Bio, Genentech, and Amgen with increasing responsibilities of scientific staff and executive management team. His career spans from discovery research, to technology and product development, to late stage process development, and to commercial operations. Dr. Luo founded GeneXP Biosciences in Boston with VC funding in the early 2000s.
Dr. Luo graduated from Virginia Tech with his Ph.D. in Microbiology and Immunology. He was trained as a postdoc at the Department of Biological Chemistry and Molecular Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School.
Speaking In
[Available On-Demand]
TOBio is an integrated CMC Solution Provider dedicated to large-scale GMP production of biologics…